BOTHELL, Wash.--(BUSINESS WIRE)--Cardiac Science (NASDAQ:CSCX), a global leader in advanced cardiac diagnosis, resuscitation, rehabilitation, and informatics products, today announced preliminary revenue results for the fourth quarter ended December 31, 2008. The Company expects total revenue of approximately $51 million for the fourth quarter and approximately $206 million for the full year 2008. This represents an increase of approximately 13% from the $182.1 million in revenue in fiscal 2007 and is in line with the Company’s earlier guidance.
